Barclays Keeps Overweight Rating on Mastercard (MA) Despite Stablecoin Concerns

Citi Stays Positive on Visa (V), Keeps Buy Rating

Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating

Craig-Hallum Reiterates a Buy Rating on Clover Health Investments (CLOV), Sets a $6 PT

Bernstein Keeps a Buy on Agilon Health (AGL) With a Price Target of $7.50

Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10